These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18923385)

  • 1. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats.
    Ikeda H; Tsuruya K; Toyonaga J; Masutani K; Hayashida H; Hirakata H; Iida M
    Kidney Int; 2009 Jan; 75(2):147-55. PubMed ID: 18923385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
    Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
    Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats.
    Pechanova O; Matuskova J; Capikova D; Jendekova L; Paulis L; Simko F
    Kidney Int; 2006 Jul; 70(1):170-6. PubMed ID: 16710350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK
    Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis.
    Bienvenu LA; Morgan J; Rickard AJ; Tesch GH; Cranston GA; Fletcher EK; Delbridge LM; Young MJ
    Endocrinology; 2012 Jul; 153(7):3416-25. PubMed ID: 22653557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats.
    Kashiwagi M; Shinozaki M; Hirakata H; Tamaki K; Hirano T; Tokumoto M; Goto H; Okuda S; Fujishima M
    J Am Soc Nephrol; 2000 Apr; 11(4):616-624. PubMed ID: 10752520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats.
    Wangensteen R; O'Valle F; Del Moral R; Vargas F; Osuna A
    Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats.
    Martín-Fernández B; Rubio-Navarro A; Cortegano I; Ballesteros S; Alía M; Cannata-Ortiz P; Olivares-Álvaro E; Egido J; de Andrés B; Gaspar ML; de Las Heras N; Lahera V; Moreno JA
    PLoS One; 2016; 11(1):e0145946. PubMed ID: 26730742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide synthase inhibitor. Involvement in macrophage and monocyte recruitment.
    Kashiwagi M; Masutani K; Shinozaki M; Hirakata H
    Nephron; 2002 Sep; 92(1):165-73. PubMed ID: 12187099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.
    Feng Y; Wang Y; Xiong J; Liu Z; Yard B; Lang F
    Kidney Blood Press Res; 2006; 29(2):94-9. PubMed ID: 16710099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis.
    Thomas SE; Andoh TF; Pichler RH; Shankland SJ; Couser WG; Bennett WM; Johnson RJ
    Kidney Int; 1998 Apr; 53(4):897-908. PubMed ID: 9551396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury.
    Fujihara CK; Sena CR; Malheiros DM; Mattar AL; Zatz R
    Am J Physiol Renal Physiol; 2006 Mar; 290(3):F632-40. PubMed ID: 16204410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?
    Fujihara CK; De Nucci G; Zatz R
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S462-5. PubMed ID: 8587446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Janus effect: two faces of aldosterone.
    Brem AS
    Kidney Int; 2009 Jan; 75(2):137-9. PubMed ID: 19116642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
    Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
    Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.